Fidelity Select Biotechnology Portfolio Current Assets

Fidelity Select Biotechnology Portfolio posts a current assets of $62M as of October 2023. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Current Assets is one piece of Fidelity Select Biotechnology Portfolio's financial statement story. At $62M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for FBIOX's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Fidelity Select Biotechnology Portfolio's other metric pages and overview cover the third.